For: | Xia LZ, Liu Y, Xu XZ, Jiang PC, Ma G, Bu XF, Zhang YJ, Yu F, Xu KS, Li H. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility. World J Gastroenterol 2014; 20(32): 11429-11438 [PMID: 25170232 DOI: 10.3748/wjg.v20.i32.11429] |
---|---|
URL: | https://www.wjgnet.com/1009-3079/full/v20/i32/11429.htm |
编号 | Citing Articles |
1 |
Yonghui Huang, Qiurui Hu, Zhenxia Wei, Li Chen, Ying Luo, Xiaojie Li, Cuiping Li. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility. Open Life Sciences 2023; 18(1) doi: 10.1515/biol-2022-0680
|
2 |
O. M. Fedota, L. V. Roschenyuk, T. V. Tyzhnenko, N. G. Puzik, V. M. Vorontsov, P. P. Ryzhko. Methotrexate effect on biochemical indices of psoriasis patients depends on MTHFR gene polymorphism. The Ukrainian Biochemical Journal 2020; 92(1): 66 doi: 10.15407/ubj92.01.066
|
3 |
Yuwei Wang, Lili Huo, Changqing Yang, Xiaofeng He. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility: an updated meta-analysis. Bioscience Reports 2023; 43(4) doi: 10.1042/BSR20222553
|
4 |
Xianchao An, Zonglin Yang, Zhengzhuang An. MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR). Medical Science Monitor 2017; 23: 2299 doi: 10.12659/MSM.901377
|
5 |
Siya Kong, Feng Ye, Yini Dang, Yifei Hua, Guoxin Zhang. Association of MTHFR C677T polymorphism with severity and localization of chronic atrophic gastritis patients without Helicobacter pylori infection: a case control study. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07208-2
|
6 |
Ersoy Öksüz, Gökhan Görgişen, Gökhan Oto, Hülya Özdemir, Abbas Aras, Murat Öksüz, İsmail Musab Gülaçar, Muhammet Hamdi Demirkol. Relationship between MTHFR Gene Polymorphisms and Gastrointestinal Tumors Development: Perspective from Eastern Part of Turkey. Journal of Investigative Surgery 2022; 35(1): 83 doi: 10.1080/08941939.2020.1824249
|
7 |
M.E. Icaza-Chávez, M.A. Tanimoto, F.M. Huerta-Iga, J.M. Remes-Troche, R. Carmona-Sánchez, A. Ángeles-Ángeles, F.J. Bosques-Padilla, J.M. Blancas-Valencia, G. Grajales-Figueroa, O.V. Hernández-Mondragón, A.I. Hernández-Guerrero, M.Á. Herrera-Servín, F.D. Huitzil-Meléndez, K. Kimura-Fujikami, E. León-Rodríguez, H. Medina-Franco, M.Á. Ramírez-Luna, C.L. Sampieri, B. Vega-Ramos, A. Zentella-Dehesa. The Mexican consensus on the detection and treatment of early gastric cancer. Revista de Gastroenterología de México (English Edition) 2020; 85(1): 69 doi: 10.1016/j.rgmxen.2019.10.001
|
8 |
Wei Xu, Yuelei Cheng, Huirong Zhu. Evaluation of an Association of Blood Homocysteine Levels With Gastric Cancer Risk From 27 Case–Control Studies. Medicine 2016; 95(20): e3700 doi: 10.1097/MD.0000000000003700
|
9 |
Xin-Li Zhu, Zhi-Zhong Liu, Sen-Xiang Yan, Wei Wang, Rui-Xia Chang, Chun-Yan Zhang, Yan Guo. Association between the MTHFR A1298C polymorphism and risk of cancer: evidence from 265 case–control studies. Molecular Genetics and Genomics 2016; 291(1): 51 doi: 10.1007/s00438-015-1082-y
|
10 |
Shu-Zhe Xie, Zhi-Zhong Liu, Jun-hua Yu, Li Liu, Wei Wang, Dao-Lin Xie, Jiang-Bo Qin. Association between the MTHFR C677T polymorphism and risk of cancer: evidence from 446 case–control studies. Tumor Biology 2015; 36(11): 8953 doi: 10.1007/s13277-015-3648-z
|
11 |
Man-Yi Sun, Li Zhang, Song-Li Shi, Jing-Na Lin, Graham R. Wallace. Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis. PLOS ONE 2016; 11(4): e0154337 doi: 10.1371/journal.pone.0154337
|
12 |
Xiaotong Zhu, Yangli Liu, Hong Zhang, Pingsheng Liu. Whole-genome RNAi screen identifies methylation-related genes influencing lipid metabolism in Caenorhabditis elegans. Journal of Genetics and Genomics 2018; 45(5): 259 doi: 10.1016/j.jgg.2018.03.005
|
13 |
Shanel Raghubeer, Tandi E. Matsha. Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks. Nutrients 2021; 13(12): 4562 doi: 10.3390/nu13124562
|
14 |
Didier Meulendijks, Jan Willem B. de Groot, Maartje Los, James E. Boers, Laurens V. Beerepoot, Marco B. Polee, Aart Beeker, Johanna E.A. Portielje, Swan H. Goey, Robert S. de Jong, Steven A.L.W. Vanhoutvin, Maria Kuiper, Karolina Sikorska, Dick Pluim, Jos H. Beijnen, Jan H.M. Schellens, Cecile Grootscholten, Margot E.T. Tesselaar, Annemieke Cats. Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first‐line treatment of patients with advanced HER2‐negative gastric cancer: A multicenter phase 2 study. Cancer 2016; 122(9): 1434 doi: 10.1002/cncr.29864
|
15 |
M.E. Icaza-Chávez, M.A. Tanimoto, F.M. Huerta-Iga, J.M. Remes-Troche, R. Carmona-Sánchez, A. Ángeles-Ángeles, F.J. Bosques-Padilla, J.M. Blancas-Valencia, G. Grajales-Figueroa, O.V. Hernández-Mondragón, A.I. Hernández-Guerrero, M.A. Herrera-Servín, F.D. Huitzil-Meléndez, K. Kimura-Fujikami, E. León-Rodríguez, H. Medina-Franco, M.A. Ramírez-Luna, C.L. Sampieri, B. Vega-Ramos, A. Zentella-Dehesa. Consenso mexicano sobre detección y tratamiento del cáncer gástrico incipiente. Revista de Gastroenterología de México 2020; 85(1): 69 doi: 10.1016/j.rgmx.2019.10.001
|